Navigation Links
Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
Date:3/25/2008

SAN MARINO, Calif., March 25 /PRNewswire/ -- Epeius Biotechnologies Corporation announced today the issue of U.S. Patent No. 7,347,998 for Targeted Gene Delivery in vivo. This patent provides additional intellectual property protection for the platform of highly advanced biotechnologies embodied in the company's leading anti-cancer agent, Rexin-G. Administered clinically by simple intravenous infusion, the Epeius tumor-targeted gene delivery system enables Rexin-G to seek out and accumulate selectively in cancerous tissues and remote metastatic tumor nodules that have spread throughout the body. Rexin-G delivers it tumor-killing payload precisely where it is needed most, by targeting cancer from the inside.

*(LOGO: Send2Press.com/mediaboom/08-0325-Epeius_72dpi.jpg)

Rexin-G demonstrates profound single agent efficacy in a broad spectrum of chemotherapy refractory cancers, including pancreatic cancer, breast cancer, colon cancer, squamous cell carcinoma of larynx, uterine cancer, gastric cancer, malignant melanoma, validating Epeius Biotechnologies' in vivo targeted gene delivery platform [Int'l J Oncol, 2006, 2007].

The response rates seen with Rexin-G are unmatched by any other tumor- targeted gene delivery system. The U.S. FDA has granted Orphan Drug Status to Rexin-G based on its performance as a single therapeutic agent in treating chemotherapy refractory pancreatic cancer. Based on its exemplary record of safety and efficacy as an anti-cancer agent in a broad spectrum of chemo- resistant tumors, Rexin-G received accelerated approval for the treatment of all solid tumors by the Philippine BFAD, leading to its registration. Currently, Rexin-G is being tested as a single therapeutic agent in three separate U.S. Phase I/II Trials for recurrent or metastatic cancers of the breast or pancreas and for bone and soft tissue sarcoma respectively. Additionally, a Phase II Registration Protocol is underway for chemo-resistant osteosarcoma in Los
'/>"/>

SOURCE Epeius Biotechnologies Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
2. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
5. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
6. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
7. Amyris Biotechnologies Announces $70 Million Series B Round
8. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
9. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
10. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
11. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...EDWOOD CITY, Calif., Nov. 24 /PRNewswire-FirstCall...nnounced that Randy Scott, Genomic Health,s Execut...r Jaffray Health Care Conference in New York City ..., To access the live and subsequently archived w...ations section of Genomic Health,s website at htt...
(Date:11/24/2009)... Program Connects Customers with Partner...ed with DNA Genotek Products , ... Genotek , a leading provider of products for biol...ation, today announced its new global partner prog...or DNA Genotek,s partner community and is designed...
(Date:11/24/2009)... SEATTLE, Nov. 24 Cell T...agement will present at the 21st Annual Piper Jaff... held December 1-2, 2009, at the New York Palace H...r 1 at 11:00 a.m. Eastern Time in Holmes 1 (4th Fl...ill be available at www.celltherapeutics.com , an...
(Date:11/23/2009)...l. You can think of it as origami very high-tech...nois have developed a technique for fabricating th...ures from thin films by coupling photolithography ...eractions. , The films, only a few microns thick,... with thicker pieces of the same material. , "Thi...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
...ATTLE, July 9 Cell Therapeutics, Inc. (CTI),(Nasd...ovements for,Patients and Providers Act of 2008, a...une 24, 2008 and the U.S. Senate on July 9, 2008, ...for therapeutic,radioimmunotherapies for an additi...In December, Congress froze reimbursement rates at...
...RINGFIELD, N.J., July 9 Adding to the issues of,m...hysician reimbursement,actions are in motion by th...l and Judicial Affairs (CEJA) and proponents to el...fied CME is part of a system which ensures,that ne...t they may be as,current as possible and maintain ...
... First sales for revolutio... Ovalum Ltd., a privately held Israeli medical dev...es of its new CiTop™ Guidewire product-line ...ulature. The devices are intended to assist in th...(CTO). These obstructions are hard to traverse and...
Other Biology Technology:Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months 2Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months 3Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months 4Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe 2
(Date:11/23/2009)... A new study by the Wildlife Conservation Society ...ge swamp in the Republic of Congopart of the "moth...last yearare becoming increasingly threatened by g...y recommends protection of the swamp forests adjac...serve after recent surveys confirmed that high den...
(Date:11/23/2009)...armington, CT Current research suggests that a co...ase. The related report by Nichols et al, "Unique...New Class of TLR2 Ligands Capable of Enhancing Aut...The American Journal of Pathology . , Multiple ...attacks the brain and spinal cord, affects nearly ...
(Date:11/23/2009)... AMES, Iowa - The only swine vaccine available for... herd infected with the virus. The vaccination mar... herd diagnosed with the pandemic flu., Iowa Sta...cience, developed the vaccine this summer and has ...in Iowa, Kansas and Illinois for several weeks., ...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Advocates Debunk Misinformation Campaign Implore Governor to Veto SB 1122 48360 1Advocates Debunk Misinformation Campaign Implore Governor to Veto SB 1122 48360 2Advocates Debunk Misinformation Campaign Implore Governor to Veto SB 1122 48360 3TUG Procedure by Texas Health Dallas Cardiologist Offers Hope to Millions of Patients 48355 1TUG Procedure by Texas Health Dallas Cardiologist Offers Hope to Millions of Patients 48355 2Hypertension among lower status employees lingers well into retirement 8771 1Hypertension among lower status employees lingers well into retirement 8771 2Hypertension among lower status employees lingers well into retirement 8771 3
... Education Foundation today awarded $6.5 million t...Gen) as part of a new partnership that extends the...ears. The program helps cultivate new scientific a... "Helios Education Foundations commitment to deve...training is an incredible boost for Arizonas futur...
...nnesburg to survey bat colonies? To Kenya to count...What about Roman ruins in Britain? Snowflakes in N...for you, in fact, an entire digital database of we...to all matter of, well, matter. And that includes ...yard lichens. , Diane Schmidt, the biology librar...
...dwestern farming has introduced the equivalent of ... over the past 50 years and is adding more carbon ...tudy published in Nature by researchers at Yale an...iscovery of a new large river being piped out of t...the study and associate professor of ecosystem eco...
Other Biology News:Helios Education Foundation invests $6.5 million 2Helios Education Foundation invests $6.5 million 3U. of I. librarian launches comprehensive Web database of field guides 2U. of I. librarian launches comprehensive Web database of field guides 3Agriculture is changing the chemistry of the Mississippi River 2
Stains-All from Sigma-Aldrich
...ancer (with betaine) substantially improves PCR pe...ificity for amplification of many DNA templates. U...s the base-pair composition dependence of DNA melt...ses pauses of DNA polymerase, and reduces secondar...
Polystyrene Plate Cover with stacking ridge from ABgene
...er for Michels Transport Fluid (cat.# MTF). Miche... specimens (such as renal biopsies and lymph nodes...ain in Transport Fluid for up to 5 days at room te...ive and is not suitable for transporting live cell...
Biology Products: